|
Anesthetics may disrupt normal synaptic transmission by interfering with the release of neurotransmitter from the presynaptic nerve terminals into the synaptic cleft, by altering the reuptake of neurotransmitter after its release, by changing the binding of neurotransmitter to receptor sites on the postsynaptic membrane, or by influencing the ionic conductance change that follows activation of the postsynaptic receptor by neurotransmitter.[37]
A presynaptic site of inhaled anesthetic action may be inferred from electrophysiologic recordings that compare postsynaptic potentials obtained through presynaptic stimulation compared with those generated by direct application of neurotransmitter. For example, in mouse hippocampal slices, glutamatergic excitatory postsynaptic currents are reduced about 50% by approximately 1 MAC of halothane, whereas halothane (even at concentrations of about 5 MAC) has no effect on the currents induced by bath application of glutamatergic agonists.[40]
A presynaptic site of action is also implied from studies that demonstrate an influence of anesthetics on neurotransmitter release.[37] [41] Clinical concentrations of inhaled agents reduce depolarization-evoked release of norepinephrine but not acetylcholine from slices of rat cerebral cortex.[42] In the rat striatum, isoflurane and halothane increase spontaneous dopamine release[43] but decrease nicotine-evoked release of dopamine and have no effect on potassium-induced GABA release.[44] Isoflurane does not alter potassium-evoked glutamate release in cerebral cortex, striatum, or hippocampus, but it inhibits Na+ channel-mediated glutamate release.[45] The ability of anesthetics to alter neurotransmitter release may depend on the biologic preparation examined, the method employed to evoke neurotransmitter release, the neurotransmitter, and the anesthetic and its concentration.
In addition to an effect on the presynaptic release of neurotransmitters, it is conceivable that inhaled anesthetics may alter the duration of neurotransmitter action by influencing the reuptake of neurotransmitter into the nerve terminal.[41] An anesthetic-induced increase in the uptake of glutamate may decrease excitatory transmission and contribute to the action of some volatile agents.[46]
Evidence is available for the postsynaptic effects of inhaled anesthetics on excitatory and inhibitory neurons. Postsynaptic sites of anesthetic action may be studied by application of putative neurotransmitters thought to act directly on postsynaptic membrane receptors.[37] Halothane and isoflurane (0.5 to 2.5 MAC) reduce the depolarizing responses to iontophoretic applications of acetylcholine or glutamate to dendrites in guinea pig neocortical slices, with the acetylcholine response being depressed more than the glutamate response. [47] Halothane and isoflurane have little or no effect on the response induced by iontophoretic application of GABA
A postsynaptic action is also evident from the ability of clinical concentrations of inhaled agents to modulate current flow through a variety of ion channels found on postsynaptic membranes (see "Membrane Proteins").[50]
In summary, inhaled anesthetics act on synaptic regions, including afferent axons at the nerve terminal. Inhaled agents alter axonal and synaptic transmission in isolated monosynaptic and polysynaptic neuronal systems and may have presynaptic and postsynaptic effects. Clinical concentrations of inhaled agents can depress, leave unchanged, or enhance presynaptic neurotransmitter release and the postsynaptic response. The effect depends on the biologic preparation, the frequency of neuronal transmission, the particular neurotransmitter, and the anesethetic examined.
|